Revealing Protective Immunity to Influenza Using Systems Immunology (NCT06501963) | Clinical Trial Compass
CompletedPhase 4
Revealing Protective Immunity to Influenza Using Systems Immunology
United States51 participantsStarted 2024-10-14
Plain-language summary
The goals of this study are to better understand the human immune response to influenza vaccines, specifically the live attenuated (weakened) influenza vaccine given as a nasal spray. Better understanding why this vaccine does not work as well in adults as it does in children may help design better influenza vaccines.
Who can participate
Age range18 Years – 49 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.